LEADER 03911nam  2201141zu 450 
001 9910698256603321
005 20251017110234.0
035   $a(CKB)2670000000410513
035   $a(SSID)ssj0000622398
035   $a(PQKBManifestationID)11348851
035   $a(PQKBTitleCode)TC0000622398
035   $a(PQKBWorkID)10638993
035   $a(PQKB)21406873
035   $a(WaSeSS)Innodata00030967
035   $a(OCoLC)71837124
035   $a(DNLM)1562013
035   $a(EXLCZ)992670000000410513
100   $a20160829d2006      uy 
101 0 $aeng
135   $aur|||||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aTesting for BNP and NT-proBNP in the diagnosis and prognosis of heart failure
210 31$a[Place of publication not identified]$cAgency for Healthcare Research and Quality$d2006
215   $a1 online resource
225 1 $aEvidence Reports/Technology Assessments ;$vno. 142
225 1 $aAHRQ publication ;$vno. 06-E014
300   $aBibliographic Level Mode of Issuance: Monograph
320   $aIncludes bibliographical references.
410  0$aEvidence report/technology assessment ;$vno. 142.
410  0$aAHRQ publication ;$vno. 06-E014.
606   $aHeart Diseases
606   $aSensitivity and Specificity
606   $aNatriuretic Peptides
606   $aNerve Tissue Proteins
606   $aDiagnosis
606   $aPeptide Hormones
606   $aProteins
606   $aEpidemiologic Research Design
606   $aCardiovascular Diseases
606   $aDiagnostic Techniques and Procedures
606   $aHealth Care Evaluation Mechanisms
606   $aHormones
606   $aPeptides
606   $aAmino Acids, Peptides, and Proteins
606   $aDisease
606   $aEpidemiologic Methods
606   $aQuality of Health Care
606   $aHormones, Hormone Substitutes, and Hormone Antagonists
606   $aPublic Health
606   $aInvestigative Techniques
606   $aHealth Care Quality, Access, and Evaluation
606   $aEnvironment and Public Health
606   $aDelivery of Health Care
606   $aPredictive Value of Tests
606   $aHeart Failure
606   $aNatriuretic Peptide, Brain
606   $aPrognosis
606   $aHealth & Biological Sciences$2HILCC
606   $aPharmacy, Therapeutics, & Pharmacology$2HILCC
615  2$aHeart Diseases.
615  2$aSensitivity and Specificity.
615  2$aNatriuretic Peptides.
615  2$aNerve Tissue Proteins.
615  2$aDiagnosis.
615  2$aPeptide Hormones.
615  2$aProteins.
615  2$aEpidemiologic Research Design.
615  2$aCardiovascular Diseases.
615  2$aDiagnostic Techniques and Procedures.
615  2$aHealth Care Evaluation Mechanisms.
615  2$aHormones.
615  2$aPeptides.
615  2$aAmino Acids, Peptides, and Proteins.
615  2$aDisease.
615  2$aEpidemiologic Methods.
615  2$aQuality of Health Care.
615  2$aHormones, Hormone Substitutes, and Hormone Antagonists.
615  2$aPublic Health.
615  2$aInvestigative Techniques.
615  2$aHealth Care Quality, Access, and Evaluation.
615  2$aEnvironment and Public Health.
615  2$aDelivery of Health Care.
615  2$aPredictive Value of Tests.
615  2$aHeart Failure.
615  2$aNatriuretic Peptide, Brain.
615  2$aPrognosis.
615  7$aHealth & Biological Sciences
615  7$aPharmacy, Therapeutics, & Pharmacology
702   $aBalion$b Cynthia
712 02$aMcMaster University Evidence-based Practice Center,
712 02$aUnited States Agency for Healthcare Research and Quality
801  0$bPQKB
906   $aBOOK
912   $a9910698256603321
996   $aTesting for BNP and NT-proBNP in the diagnosis and prognosis of heart failure$93211945
997   $aUNINA